株探米国株
日本語 英語
エドガーで原本を確認する
false 0000746210 0000746210 2024-12-31 2024-12-31
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): March 18, 2025
 
OBLONG, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of
Incorporation or organization)
001-35376
(Commission File Number)
77-0312442
(IRS Employer
Identification No.)
 
110 16th Street, Suite 1400 - 1024
Denver, Colorado 80202
(Address of principal executive offices, zip code)
 
 
(213) 683-8863 ext. 5
(Registrant’s telephone number, including area code)
 
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a‑12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
 
OBLG
 
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 






 
Item 2.02 Results of Operations and Financial Condition.
 
On March 18, 2025, Oblong, Inc., a Delaware corporation (the “Company”), issued a press release announcing the Company’s financial results for the year ended December 31, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated in this Item 2.02 by reference.
 
The information contained in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, whether made before or after the date hereof, and regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.
 
 
9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit No.
Description
99.1
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 






 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
OBLONG, INC.
 
 
Date: March 18, 2025                    By:    /s/ Peter Holst        
Name: Peter Holst
Title: President & CEO
 
 
 
 
EX-99.1 2 ex_704983.htm EXHIBIT 99.1 ex_688564.htm
header1.jpg

EXHIBIT 99.1

 

Oblong Announces Financial Results for Fourth Quarter 2024 and Provides Business Update

 

March 18, 2025 -- (BUSINESS WIRE) Oblong, Inc. (Nasdaq: OBLG) (“Oblong” or the “Company”), an innovator in collaboration solutions, today reported financial results for the fourth quarter and fiscal year ending December 31, 2024, and provided updates on the Company's business and strategy.

 

“As of December 31, 2024, our financial footing remains strong, with $5.0 million in cash and zero debt. During Q4, we raised $231,000 from common stock warrant exercises and streamlined operations to increase efficiency, resulting in expected annual savings of $1.2 million. We believe we’re on track to maintain liquidity into mid-2026. In September 2024, we proudly regained full compliance with Nasdaq’s listing standards. Our focus is now on identifying impactful growth avenues, including mergers and acquisitions, to fuel a new phase of expansion. We’re exploring a range of strategic possibilities—from potential business combinations and reverse mergers to a potential sale of certain assets to further expand liquidity and narrow our operating focus. Each pathway is being evaluated to maximize sustainable growth and unlock new value for our stakeholders,” said Peter Holst, CEO of Oblong.

 

Fourth Quarter 2024 Financial Results

 

 

As of December 31, 2024, the Company had $5.0 million of cash and cash equivalents and no debt.

 

 

Total revenue was $0.6 million for the fourth quarter of 2024 versus $0.9 million for the fourth quarter of 2023.

 

 

Net loss was $0.9 million for the fourth quarter of 2024 versus $1.2 million for the fourth quarter of 2023.

 

 

Adjusted EBITDA (“AEBITDA”) loss was $0.9 million for both the fourth quarter of 2024 and the fourth quarter of 2023. AEBITDA loss is a non-GAAP financial measure. See “Non-GAAP Financial Information” below for additional information regarding this non-GAAP financial measure, and “GAAP to Non-GAAP Reconciliation” for a reconciliation of this non-GAAP financial measure to net loss.

 

Non-GAAP Financial Information

 

Adjusted EBITDA (“AEBITDA”) loss, a non-GAAP financial measure, is defined as net loss before amortization, stock-based compensation and expense, impairment charges, casualty gain (insurance proceeds), income tax expense, and interest income, net. AEBITDA loss is not intended to replace operating loss, net loss, cash flow, or other measures of financial performance reported in accordance with generally accepted accounting principles (GAAP). Rather, AEBITDA loss is an important measure used by management to assess the operating performance of the Company and to compare such performance between periods. AEBITDA loss, as defined here, may not be comparable to similarly titled measures reported by other companies due to differences in accounting policies. Therefore, AEBITDA loss should be considered in conjunction with net loss and other performance measures prepared in accordance with GAAP, such as operating loss or cash flow used in operating activities, and should not be considered in isolation or as a substitute for GAAP measures, such as net loss, operating loss or any other GAAP measure of liquidity or financial performance. A GAAP to non-GAAP reconciliation of net loss to AEBITDA loss is shown under “GAAP to Non-GAAP Reconciliation” later in this release.

 

About Oblong, Inc.

 

Oblong (Nasdaq: OBLG) provides innovative and patented technologies that change how people work, create, and communicate. Oblong’s flagship product Mezzanine™ is a remote meeting technology platform that offers simultaneous content sharing to achieve situational awareness for both in-room and remote collaborators. Oblong supplies Mezzanine systems to Fortune 500 and enterprise customers. For more information, visit www.oblong.com and Oblong’s Twitter and Facebook pages.

 







header1.jpg

Forward-looking and cautionary statements

 

This press release and any oral statements made regarding the subject of this release contain forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, that address activities that Oblong assumes, plans, expects, believes, intends, projects, estimates, or anticipates (and other similar expressions) will, should, or may occur in the future are forward-looking statements. Oblong’s actual results may differ materially from its expectations, estimates, and projections, and consequently, you should not rely on these forward-looking statements as predictions of future events. Without limiting the generality of the foregoing, forward-looking statements contained in this press release include statements relating to (i) the Company’s exploration of strategic alternatives, including the Company’s goal to forge partnerships with select early-stage technology companies and the mission to deliver innovative technology solutions, and (ii) the Company’s liquidity and operating expense projections. There can be no assurance that the strategic review being undertaken will result in a merger, sale, or other business combination involving the Company. The forward-looking statements are based on management’s current belief, based on currently available information, as to the outcome and timing of future events and involve factors, risks, and uncertainties, including the volatility of market price for our securities, that may cause actual results in future periods to differ materially from such statements. A list and description of these and other risk factors can be found in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and in other filings made by the Company with the SEC from time to time. Any of these factors could cause Oblong’s actual results and plans to differ materially from those in the forward-looking statements. Therefore, the Company cannot give any assurance that its future results will be as estimated. The Company does not intend to, and disclaims any obligation to, correct, update, or revise any information contained herein.

 

Investor Relations Contact

David Clark

investors@oblong.com

(213) 683-8863 ext. 5

 







header1.jpg

OBLONG, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

($ in thousands, except par value and stated value)

 

   

December 31,

   

December 31,

 
   

2024

   

2023

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 4,965     $ 5,990  

Accounts receivable, net

    186       424  

Inventory, net

          239  

Prepaid expenses and other current assets

    118       243  

Total current assets

    5,269       6,896  

Operating lease, right-of-use assets, net

          17  

Other assets

    6       12  

Total assets

  $ 5,275     $ 6,925  

LIABILITIES AND STOCKHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

    105       211  

Accrued expenses and other current liabilities

    1,131       1,038  

Current portion deferred revenue

    36       132  

Operating lease liabilities, current

          17  

Total current liabilities

    1,272       1,398  

Long-term liabilities:

               

Deferred revenue, net of current portion

          26  

Total long-term liabilities

          26  

Total liabilities

    1,272       1,424  

Commitments and contingencies (see Note 14)

               

Stockholders’ equity:

               

Preferred stock Series F, convertible; $.0001 par value; $573,555 stated value; 42,000 shares authorized, 545 and 1,930 shares issued and outstanding on December 31, 2024 and December 31, 2023, respectively

           

Common stock, $.0001 par value; 150,000,000 shares authorized; 1,144,926 shares issued and 1,144,737 shares outstanding on December 31, 2024, respectively, and 573,644 shares issued and 573,455 outstanding on December 31, 2023, respectively

           

Treasury stock, 189 common shares on December 31, 2024 and 2023

    (181 )     (181 )

Additional paid-in capital

    236,458       233,913  

Accumulated deficit

    (232,274 )     (228,231 )

Total stockholders’ equity

    4,003       5,501  

Total liabilities and stockholders’ equity

  $ 5,275     $ 6,925  

 







header1.jpg

OBLONG, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

($ in thousands) (Unaudited)

 

   

Three Months Ended

   

Year Ended

 
   

December 31,

   

December 31,

 
   

2024

   

2023

   

2024

   

2023

 

Revenue

  $ 563     $ 944     $ 2,378     $ 3,810  

Cost of revenue (exclusive of amortization)

    428       655       2,047       2,899  

Gross profit

    135       289       331       911  

Operating expenses:

                               

Research and development

    2       4       155       20  

Sales and marketing

    4       68       181       309  

General and administrative

    1,058       1,147       4,197       4,870  

Amortization

          86             345  

Impairment charges

          260             262  

Casualty gain (insurance proceeds)

                      (400 )

Total operating expenses

    1,064       1,565       4,533       5,406  

Operating loss

    (929 )     (1,276 )     (4,202 )     (4,495 )

Interest income, net

    (45 )     (44 )     (169 )     (138 )

Loss before income taxes

    (884 )     (1,232 )     (4,033 )     (4,357 )

Income tax expense

          (11 )     10       27  

Net loss

  $ (884 )   $ (1,221 )   $ (4,043 )   $ (4,384 )

 

GAAP to Non-GAAP Reconciliation:

 

   

Three Months Ended

   

Year Ended

 
   

December 31,

   

December 31,

 
   

2024

   

2023

   

2024

   

2023

 

Net loss

  $ (884 )   $ (1,221 )   $ (4,043 )   $ (4,384 )

Amortization

          86             345  

Severance

                105        

Interest income, net

    (45 )     (44 )     (169 )     (138 )

Income tax expense

          (11 )     10       27  

Impairment charges

          260             262  

Casualty gain (insurance proceeds)

                      (400 )

Stock-based compensation and expense

          31       62       504  

Adjusted EBITDA loss

  $ (929 )   $ (899 )   $ (4,035 )   $ (3,784 )